February brought policy updates and several biosimilar approvals, including the first FDA approval for an insulin aspart ...
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
Number 4: Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab biosimilar candidate (Stoboclo and Osenvelt) and its aflibercept ...
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
At what was supposed to be a hearing to discuss PBM reform, some in Congress veered off into discussions about Medicaid and ...
The US FDA has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes.
The new lower prices apply to some doses of Zepbound provided in vials but not the autoinjector pens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback